Osborne David W
- SEC CIK
- 0001252999
No open-market purchases or sales filed in the past year.
Current role at each company
- ARQT Arcutis Biotherapeutics, Inc.Chief Technical Officeras of Mar 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Osborne David W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 (view filing) | Mar 6 | 2 days | Osborne David WChief Technical Officer | SSale | −690 | $15.26 | −$10.5K | −0.3%268.9K after | |
| Mar 2, 2023 (view filing) | Feb 28-Mar 2 | 2 days | Osborne David WChief Technical Officer | SSale | −2.00K | $15.96 | −$32.0K | −0.8%254.6K after | 3 lots |
| Jul 12, 2022 (view filing) | Jul 8 | 4 days | Osborne David WChief Technical Officer | SSale | −2.20K | $25.41 | −$55.8K | −0.8%256.6K after | |
| Apr 21, 2022 (view filing) | Apr 21 | Same day | Osborne David WChief Technical Officer | SSale | −2.20K | $20.42 | −$44.9K | −0.8%257.2K after | |
| Mar 7, 2022 (view filing) | Mar 4-7 | 3 days | Osborne David WChief Technical Officer | SSale | −856 | $16.85 | −$14.4K | −0.3%259.4K after | 2 lots |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Osborne David WChief Technical Officer | SSale | −775 | $17.75 | −$13.8K | −0.3%247.0K after |